{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:16:57Z","timestamp":1783142217028,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Telethon Foundation","doi-asserted-by":"publisher","award":["GMR22T2019"],"award-info":[{"award-number":["GMR22T2019"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RF-2019\\u201312370417"],"award-info":[{"award-number":["RF-2019\\u201312370417"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.phrs.2026.108234","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:06:53Z","timestamp":1778170013000},"page":"108234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacological restoration of mitochondrial permeability transition pore flickering by high-content drug repurposing"],"prefix":"10.1016","volume":"229","author":[{"given":"Emanuela","family":"Franchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bulloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sorgente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Paulikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cassina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Marafelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Sambri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Pattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0115-8980","authenticated-orcid":false,"given":"Giorgio","family":"Casari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108234_bib1","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41418-023-01187-0","article-title":"Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions","volume":"30","author":"Bernardi","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.phrs.2026.108234_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14728222.2024.2306337","article-title":"Mitochondrial permeability transition pore: a snapshot of a therapeutic target","volume":"28","author":"Zoratti","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.phrs.2026.108234_bib3","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/01.CIR.0000126294.81407.7D","article-title":"Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection","volume":"109","author":"Hausenloy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108234_bib4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1152\/physrev.00001.2015","article-title":"The mitochondrial permeability transition pore: channel formation by F-ATP synthase, integration in signal transduction, and role in pathophysiology","volume":"95","author":"Bernardi","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2026.108234_bib5","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1038\/s44318-024-00259-2","article-title":"Cyclophilin D plays a critical role in the survival of senescent cells","volume":"43","author":"Protasoni","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2026.108234_bib6","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)81203-9","article-title":"Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease","volume":"93","author":"Casari","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.108234_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103050","article-title":"Impaired flickering of the permeability transition pore causes SPG7 spastic paraplegia","volume":"61","author":"Sambri","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phrs.2026.108234_bib8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1172\/JCI0216029","article-title":"Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility","volume":"110","author":"Blatt","year":"2002","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2026.108234_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2026.108234_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20624","article-title":"Mitochondria take center stage in aging and neurodegeneration","volume":"58","author":"Beal","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2026.108234_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-319-41334-1_2","article-title":"Berberine and its role in chronic disease","volume":"928","author":"Cicero","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phrs.2026.108234_bib12","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank Knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.phrs.2026.108234_bib13","first-page":"1067","article-title":"The IUPHAR\/BPS Guide to PHARMACOLOGY in 2026","volume":"2025","author":"Harding","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.phrs.2026.108234_bib14","unstructured":"Ahsen.M.-Analyzer, 2019. G. Chaudhry, Mitochondria Analyzer Version 2.3.1, \u3008Https:\/\/Github.Com\/AhsenChaudhry\/Mitochondria-Analyzer\u3009 (2019)."},{"key":"10.1016\/j.phrs.2026.108234_bib15","first-page":"990","article-title":"Labeling mitochondria with MitoTracker dyes","volume":"2011","author":"Chazotte","year":"2011","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.phrs.2026.108234_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.845591","article-title":"Berberine: a promising treatment for neurodegenerative diseases","volume":"13","author":"Cheng","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.phrs.2026.108234_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810633","article-title":"Effect of chronic treatment with uridine on cardiac mitochondrial dysfunction in the C57BL\/6 mouse model of high-fat diet-streptozotocin-induced diabetes","volume":"23","author":"Belosludtseva","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108234_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112640","article-title":"Repurposing ezetimibe as a neuroprotective agent in a rotenone-induced Parkinson\u2019s disease model in rats: role of AMPK\/SIRT-1\/PGC-1\u03b1 signaling and autophagy","volume":"138","author":"Elesawy","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2026.108234_bib19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s12272-020-01243-0","article-title":"The pharmacological and biological roles of eriodictyol","volume":"43","author":"Islam","year":"2020","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.phrs.2026.108234_bib20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/jcmm.13975","article-title":"Vildagliptin improves high glucose-induced endothelial mitochondrial dysfunction via inhibiting mitochondrial fission","volume":"23","author":"Liu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108234_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1756285613512712","article-title":"4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review","volume":"7","author":"Jensen","year":"2014","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.phrs.2026.108234_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1021\/jm8012932","article-title":"Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist, J","volume":"52","author":"Griffith","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.phrs.2026.108234_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233859","article-title":"Effects of Biotin on survival, ensheathment, and ATP production by oligodendrocyte lineage cells in vitro","volume":"15","author":"Cui","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2026.108234_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1358\/dot.2007.43.3.1062673","article-title":"Lumiracoxib","volume":"43","author":"Buvanendran","year":"2007","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.phrs.2026.108234_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2003.12.026","article-title":"Potentiated anticancer effects on hepatoma cells by the retinoid adapalene","volume":"208","author":"Ocker","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2026.108234_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/iub.1364","article-title":"Dose-dependent effect of 2-deoxy-D-glucose on glycoprotein mannosylation in cancer cells","volume":"67","author":"Ahadova","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.phrs.2026.108234_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104548","article-title":"A novel class of cardioprotective small-molecule PTP inhibitors","volume":"151","author":"Antonucci","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2026.108234_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1023\/B:JOBB.0000041776.31885.45","article-title":"The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria","volume":"36","author":"Hansson","year":"2004","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.phrs.2026.108234_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ceca.2005.06.011","article-title":"Mitochondria and calcium signaling","volume":"38","author":"Nicholls","year":"2005","journal-title":"Cell Calcium"},{"key":"10.1016\/j.phrs.2026.108234_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237368","article-title":"Berberine as a potential anticancer agent: a comprehensive review","volume":"26","author":"Rauf","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2026.108234_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8040090","article-title":"The quest to enhance the efficacy of berberine for type-2 diabetes and associated diseases: physicochemical modification approaches","volume":"8","author":"Habtemariam","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108234_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010219","article-title":"Berberine Induces Mitophagy through Adenosine Monophosphate-Activated Protein Kinase and Ameliorates Mitochondrial Dysfunction in PINK1 Knockout Mouse Embryonic Fibroblasts","volume":"25","author":"Um","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108234_bib33","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1248\/bpb.b24-00463","article-title":"Different Effects of Berberine Delivery to Mitochondria on Cells Derived from the Neural Crest","volume":"47","author":"Hori","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phrs.2026.108234_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24020903","article-title":"Development of a Mitochondrial Targeting Lipid Nanoparticle Encapsulating Berberine","volume":"24","author":"Hori","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108234_bib35","article-title":"Berberine is a Novel Mitochondrial Calcium Uniporter Inhibitor that Disrupts MCU-EMRE Assembly This binding disrupts the interaction of MCU with its essential regulator, EMRE, thereby inhibiting rapid Ca 2+ entry into the mitochondria","author":"Zhao","year":"2025","journal-title":"Notably Berberine\u2026"},{"key":"10.1016\/j.phrs.2026.108234_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28952-3","article-title":"Cell-specific pattern of berberine pleiotropic effects on different human cell lines","volume":"8","author":"Agnarelli","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108234_bib37","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1210\/jc.2007-2404","article-title":"Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine","volume":"93","author":"Zhang","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2026.108234_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jep.2014.09.049","article-title":"Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension","volume":"161","author":"Lan","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2026.108234_bib39","article-title":"Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108234_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.62185","article-title":"Berberine ursodeoxycholate for the treatment of type 2 diabetes: a randomized clinical trial","volume":"8","author":"Ji","year":"2025","journal-title":"JAMA Netw. Open"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:38:44Z","timestamp":1783139924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826001490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":40,"alternative-id":["S1043661826001490"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108234","relation":{"has-preprint":[{"id-type":"doi","id":"10.64898\/2026.01.23.701330","asserted-by":"object"}]},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological restoration of mitochondrial permeability transition pore flickering by high-content drug repurposing","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108234"}}